More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma-Reference-Cited by-同舟云学术

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma

Published:2017-11-03 Issue:5 Volume:38 Page:895-902
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Jun Tomi W.¹,Yeh Ming-Lun²,Yang Ju Dong³,Chen Vincent L.¹⁴,Nguyen Pauline¹,Giama Nasra H.³,Huang Chung-Feng²,Hsing Ann W.⁵,Dai Chia-Yen²,Huang Jee-Fu²,Chuang Wan-Long²,Roberts Lewis R.³,Yu Ming-Lung²,Nguyen Mindie H.¹^ORCID

Affiliation:

1. Division of Gastroenterology and Hepatology; Stanford University Medical Center; Stanford CA USA

2. Hepatobiliary Division; Department of Internal Medicine and Hepatitis Center; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Taiwan

3. Division of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN USA

4. Division of Gastroenterology; University of Michigan Health System; Ann Arbor MI USA

5. Stanford Prevention Research Center; Stanford Cancer Institute; Stanford CA USA

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13613/fullpdf

Reference27 articles.

1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived With disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;Fitzmaurice;JAMA Oncol,2016

2. Incidence and survival of adult cancer patients in Taiwan, 2002-2012;Chiang;J Formos Med Assoc,2016

3. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

4. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide;Perz;J Hepatol,2006

5. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years;Powell;Hepatology,1990

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in characteristics and survival rates of cirrhosis in a nationwide cohort of real‐world U.S. patients, 2003–2021;Alimentary Pharmacology & Therapeutics;2024-05

2. Berberine prevents NAFLD and HCC by modulating metabolic disorders;Pharmacology & Therapeutics;2024-02

3. Updates in Characteristics and Survival Rates of Hepatocellular Carcinoma in a Nationwide Cohort of Real-World US Patients, 2003–2021;Journal of Hepatocellular Carcinoma;2023-12

4. Short- and long-term outcomes of laparoscopic liver resection for non-alcoholic fatty liver disease-associated hepatocellular carcinoma: a retrospective cohort study;HPB;2023-12

5. Impact and usefulness of the transition to the new MAFLD classification for non-B, non-C HCC: a retrospective cohort study;BMC Gastroenterology;2023-06-28